We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

128 hedge funds and large institutions have $536M invested in IVERIC bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $2.26M | Put options by funds: $737K

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more funds holding

Funds holding: 115128 (+13)

8% more capital invested

Capital invested by funds: $495M → $536M (+$40.8M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 39

Holders
128
Holders Change
+13
Holders Change %
+11.3%
% of All Funds
2.23%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
25
Increased
39
Reduced
39
Closed
12
Calls
$2.26M
Puts
$737K
Net Calls
+$1.52M
Net Calls Change
-$1.61M
Name Holding Trade Value Shares
Change
Change in
Stake
OCA
26
Octagon Capital Advisors
New York
$4.29M
CS
27
Candriam SCA
Luxembourg
$4.26M +$4.36M +675,575 New
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$3.41M +$1.74M +269,640 +99%
SCM
29
Stonepine Capital Management
Oregon
$3.27M -$2.31M -357,735 -41%
SFM
30
Sphera Funds Management
Israel
$3.15M +$3.23M +500,000 New
Deutsche Bank
31
Deutsche Bank
Germany
$2.83M +$14.9K +2,306 +0.5%
Morgan Stanley
32
Morgan Stanley
New York
$2.57M +$2.44M +378,856 +1,320%
TA
33
Tamarack Advisers
California
$2.52M -$1.13M -175,000 -30%
Citadel Advisors
34
Citadel Advisors
Florida
$2.5M -$3.23M -500,791 -56%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$2.27M +$746K +115,600 +47%
N
36
Nuveen
North Carolina
$2.15M -$2.79M -432,156 -56%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.9M -$275K -42,581 -12%
Two Sigma Investments
38
Two Sigma Investments
New York
$1.87M +$701K +108,665 +58%
TD Asset Management
39
TD Asset Management
Ontario, Canada
$1.69M +$260K +40,250 +26%
MPAM
40
Monarch Partners Asset Management
Massachusetts
$1.63M +$894K +138,505 +115%
JG
41
Jefferies Group
New York
$1.58M +$1.61M +250,000 New
MS
42
Maven Securities
Jersey
$1.47M +$1.56M +242,289 New
Charles Schwab
43
Charles Schwab
California
$1.43M +$130K +20,105 +10%
First Trust Advisors
44
First Trust Advisors
Illinois
$1.34M -$38.8K -6,009 -3%
CC
45
Caxton Corporation
New Jersey
$1.28M +$362K +56,048 +38%
DCM
46
DAFNA Capital Management
California
$1.14M +$581K +90,000 +100%
Citigroup
47
Citigroup
New York
$971K -$293K -45,375 -23%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$789K +$22K +3,415 +3%
HS
49
HighVista Strategies
Massachusetts
$751K -$143K -22,090 -16%
AA
50
ALPS Advisors
Colorado
$750K -$285K -44,211 -27%

ISEE Hedge Fund Activity: Q2 2021 in Review

128 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2021, worth a combined $536M — up 8.2% from $495M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ISEE positions and 12 closed out — a net gain of 13 holders — while 39 added to existing stakes and 39 trimmed.

The largest buyer was Yiheng Capital Management, adding an estimated $14.7M. The largest seller was Avoro Capital Advisors, cutting an estimated $5.32M.

  • 128 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2021, up from 115 in Q1 2021.
  • Funds reported $536M of IVERIC bio, Inc. Common Stock stock for Q2 2021, up 8.2% quarter-over-quarter.
  • 25 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2021 and 12 closed out, a net change of +13 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2021 was Yiheng Capital Management, an estimated $14.7M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2021 was Avoro Capital Advisors, an estimated $5.32M sold.

Based on aggregated 13F filings for Q2 2021.